Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC | $14.49 | N/A | N/A | -0.21x | -2.44x | N/A | -5.22x | N/A | -$149.85M | -24.04% | -$150.42M | -3.50 | $618.05M | -0.71 | ||
| VKTX | VIKING THERAPEUTICS INC | $30.38 | N/A | N/A | -7.32x | -6.36x | N/A | 7.03x | N/A | -$340.33M | -9.69% | $501.92M | 4.34 | $3.41B | -7.22 | ||
| CCCC | C4 THERAPEUTICS INC | $4.15 | N/A | N/A | -3.77x | -4.16x | 14.98x | 1.96x | N/A | -$96.02M | -18.36% | $234.25M | 1.86 | $452.58M | -4.74 | ||
| AKTS | AKTIS ONCOLOGY INC | $24.09 | N/A | N/A | N/A | -13.50x | N/A | 2.54x | N/A | N/A | N/A | $506.11M | 10.41 | $925.32M | N/A | ||
| PEPG | PEPGEN INC | $1.79 | N/A | N/A | -1.23x | -1.52x | N/A | 0.92x | N/A | -$77.27M | -62.46% | $133.98M | 1.94 | $96.68M | -1.28 | ||
| RACE | FERRARI NV | $362.13 | $107.85 | 235.76% | 34.24x | N/A | 7.54x | 13.42x | 2.33x | $2.18B | 3.42% | $4.76B | 26.98 | $65.23B | 19.82 | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $11.91 | N/A | N/A | -22.90x | -17.43x | N/A | 4.16x | N/A | -$35.14M | -3.27% | $240.68M | 2.67 | $962.25M | -21.84 | ||
| BNTX | BIONTECH SE | $90.89 | N/A | N/A | -15.24x | -19.96x | 6.61x | 0.99x | N/A | $750.94M | 3.44% | $22.00B | 91.67 | $10.67B | -13.65 | ||
| SAIL | SAILPOINT INC | $13.33 | N/A | N/A | -49.37x | 41.08x | 6.71x | 1.10x | N/A | $184.98M | 2.46% | $6.84B | 12.12 | $7.17B | 569.16 | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $8.60 | $4.00 | 115.18% | 14.33x | N/A | 0.66x | 0.53x | 3.43x | $37.99M | 15.31% | $466.75M | 16.18 | $183.30M | 1.94 | ||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $7.53 | N/A | N/A | -2.66x | -1.79x | 3.91x | 1.12x | N/A | -$58.63M | -27.40% | $191.36M | 6.73 | $22.33M | -0.29 | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $4.26 | N/A | N/A | -6.45x | N/A | 3.22x | 2.15x | N/A | -$114.48M | -11.92% | $529.36M | 2.35 | $1.19B | 37.53 | ||
| EQT | EQT CORP | $50.72 | $27.98 | 81.26% | 9.53x | 10.58x | 3.08x | 1.26x | 4,604.94x | $4.05B | 12.78% | $25.12B | 40.18 | $37.45B | 5.10 | ||
| REAX | REAL BROKERAGE INC | $1.76 | N/A | N/A | -58.67x | -103.53x | 0.19x | 5.64x | N/A | $72.20M | 18.35% | $65.69M | 0.29 | $287.62M | -63.58 | ||
| GT | GOODYEAR TIRE & RUBBER CO | $6.19 | N/A | N/A | -0.85x | -18.62x | 0.10x | 0.59x | N/A | -$126.00M | -7.08% | $3.00B | 10.43 | $9.09B | 9.17 | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $7.56 | N/A | N/A | -0.01x | -3.32x | N/A | 1.63x | N/A | -$149.71M | -24.75% | $372.28M | 4.65 | $555.46M | -3.62 | ||
| SLDB | SOLID BIOSCIENCES INC | $8.33 | N/A | N/A | -4.27x | -4.30x | N/A | 2.19x | N/A | -$172.78M | -18.88% | $374.13M | 3.41 | $543.01M | -2.89 | ||
| PCVX | VAXCYTE INC | $51.44 | N/A | N/A | -7.48x | -6.25x | N/A | 2.48x | N/A | -$814.94M | -11.36% | $3.00B | 21.48 | $7.28B | -7.91 | ||
| CGEM | CULLINAN THERAPEUTICS INC | $15.03 | N/A | N/A | -4.46x | -4.64x | N/A | 2.52x | N/A | -$178.69M | -19.66% | $366.17M | 6.06 | $851.02M | -3.86 | ||
| ORIC | ORIC PHARMACEUTICALS INC | $8.49 | N/A | N/A | -6.02x | -5.73x | N/A | 2.11x | N/A | -$111.20M | -12.41% | $415.56M | 3.94 | $822.47M | -6.14 | ||
| XE | X-ENERGY INC | $21.56 | N/A | N/A | N/A | -43.91x | N/A | -4.47x | N/A | N/A | N/A | -$1.39B | -4.82 | $5.99B | N/A | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $2.95 | N/A | N/A | -2.11x | -2.49x | 491.67x | 0.97x | N/A | -$107.32M | -35.12% | $347.44M | 3.35 | $286.70M | -2.66 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.